Table 3 Change in echocardiographic LV mass from baseline to year-1 according to the presence or absence of regression of electrocardiographic LVH by the Cornell voltage–duration product

From: Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study

Variable Change in Cornell product  
  Progression (increase, n=143) No significant decrease (<25% decrease, n=286) Regression (25% decrease, n=155) Overall P-value
Gender-adjusted     
LV mass (g) −16±33 −29±37b −32±41b,c <0.001
LV mass (%) −5.7±14.6 −11.3±13.6b −12.3±15.6b,c <0.001
Multivariate a     
LV mass (g) −17±37 −28±38b −31±38b,c 0.002
LV mass (%) −6.0±14.3 −11.2±15.2b −12.4±14.9b,c <0.001
  1. aAdjusted for age, sex, baseline DBP, and change in SBP and DBP from baseline to year 1.
  2. bP<0.05 vs progression group.
  3. cP<0.05 vs no significant decrease group.
  4. Data are expressed as mean±s.d.